3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Sarcoma
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive
1
Neoplasm Metastasis
1
Melanoma
1
Glioma
1
Glioblastoma
1
Castration Resistant Prostate Cancer
1
Interventions
bintrafusp alfa protein, human
1
Triamcinolone Acetonide
1
TH 302
1
Injections, Intramuscular
1
ALT-803
1
AGN 194204
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Castration Resistant Prostate Cancer
×
TH 302
×
Clear all
NCT06836726
2026-01-28
EVO
University Health Network, Toronto
Phase 2
Not yet recruiting
35 enrolled